期刊文献+

辽西地区糖尿病患者标准治疗情况调查

A survey of standard treatment of diabetes in western Liaoning
下载PDF
导出
摘要 目的了解辽西地区糖尿病患者的标准治疗情况,评价患者心脑血管疾病的风险,为进一步提高标准治疗率提供依据。方法以1 000例糖尿病患者为调查对象,通过调查问卷、访谈的方式,收集患者的年龄、性别、糖尿病的诊断年限、文化程度等基本资料,以及是否使用阿司匹林、血压控制、血脂管理等信息。结果入选的941例患者的年龄为(59.6±11.2)岁,病程为(9±6.7)年。研究人群中有381例患者合并高血压,约68.8%的患者长期服用降压药物治疗。在过去一年中约有2/3的患者检测过血脂,其中393例(41.8%)患者血脂异常,约有59.8%的患者接受调脂药物治疗。研究人群中有阿司匹林适应证的患者为807人(85.8%),目前应用阿司匹林的患者约占41.2%。综合评估,941例患者中有844例存在心血管危险因素(包括年龄),接受ABC标准治疗的只有25.7%。结论辽西地区的糖尿病患者标准治疗的水平与理想目标之间还有很大差距,应进一步采取措施提高标准治疗水平。 Objective To understand the standard treatment of diabetic patients in western Li- aoning province, the evaluation of patients with cardiovascular and cerebrovascular disease risk, and provide a basis to further improve the standard treatment rate. Methods One thou- sand patients with diabetes mellitus (DM) for the survey through questionnaires, interviews, collecting the age, gender, life of the diagnosis of diabetes, education and other basic informa- tion, and whether the use of aspirin, blood pressure control, lipid management and other infor- mation. Results There were 941 DM patients selected, mean age (59.6 ± 11.2) years, and with a mean duration of (9.0 ±6. 7) years. Among them, 381 patients with hypertension, and about 68.8 percent had long-term use of antihypertensive medication. About two-thirds of the patients had detected lipids in the past year, of which 393 cases (41.8%) patients with dys- lipidemia, and about 59. 8% patients receiving lipid-lowering medication. Among 807 patients with aspirin indications, there were 85.8% patients took aspirin, accounting for about 41.2%. Comprehensive assessment of 941 patients, there were 844 cases of cardiovascular risk factors (including age), only 25.7% of them received ABC standard treatment. Conclusion The level of diabetic patients with standard therapy in western Liaoning province still has a big gapto the ideal goal, and should take further measures to raise the level of the standard treatment.
出处 《哈尔滨医科大学学报》 CAS 北大核心 2013年第1期75-77,共3页 Journal of Harbin Medical University
基金 国家自然科学基金资助项目(31100858) 辽宁省科技攻关计划项目(2011225015)
关键词 糖尿病 高血压 高脂血症 阿司匹林 diabetes mellitus hypertension hyperlipidemia aspirin
  • 相关文献

参考文献8

  • 1Tsujimoto T, Kajio H, Takahashi Y, et al. Asymptomatic coronary heart disease in patients with type 2 diabetes with vascular compli- cations: a cross-sectional study [ J ]. BMJ Open, 2011,1 (2) : e000139.
  • 2Vouri SM, Shaw RF, Waterbury N, et al. Prevalence of a- chievement of Alc, blood pressure, and cholesterol (ABC) goal in veterans with diabetes [J]. J Manag Care Pharm, 2011,17 (4) :304-312.
  • 3Saydah SH, EberhardtM S, Loria CM, et al. Age and the burden of death attributable to diabetes in the United States [ J ]. Am J Ep- idemiol, 2002,156(8) :714-719.
  • 4Vaag AA. Glycemic control and prevention of microvascular and macrovascular disease in the Steno 2 study [ J ]. Endocr Pract, 2006,12( Suppl 1 ) :89-92.
  • 5Davis TM, Colagiuri S. The continuing legacy of the United King- dom Prospective Diabetes Study [ J ]. Med J Aust, 2004,180 ( 3 ) : 104-105.
  • 6肖骅,周建庆,葛世俊,高丛光,赵维庆,陈文采,柳俊平,沈文均,周军波.阿司匹林与血管紧张素转换酶抑制剂合用对急性心肌梗死伴心力衰竭预后的影响[J].实用医学杂志,2005,21(13):1459-1460. 被引量:2
  • 7Peto R, Gray R, Collins R, et al. Randomised trial of prophylac- tic daily aspirin in British male doctors[ J]. Br Med J, 1988,296 (6618) :313-316.
  • 8Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low- dose aspirin in the primary prevention of cardiovascular disease in women [ J ]. N Engl J Med, 2005,352 ( 13 ) : 1293-1304.

二级参考文献10

  • 1Teo KK, Yusuf S, Pfeffer M, et al. Effects of long- term treatment with angiotensin- converting- enzyme inhibitors in the presence or absence of aspirin: a systematic review. Lancet, 2002, 360(9339): 1037-1043
  • 2Ahmed A. Interaction between aspirin and angiotensin- converting enzyme inhibitors: should they be used together in older adults with heart failure? J Am Geriatr Soc, 2002, 50(7): 1293-1296
  • 3The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet, 1993, 342(8875): 821-828
  • 4Vaughan DE, Rouleau JL, Ridker PM, et al. Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators. Circulation, 1997, 96(2): 442-447
  • 5Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin- converting enzyme inhibitor, ramipril, on cardiovascular events in high- risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med, 2000, 342(3): 145-153
  • 6Antiplatet ' Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy- I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J, 1994, 308(6921): 81-106
  • 7Konstam MA. Aspirin and heart failure: square evidence meets a round patient. CHF , 2003, 9(4): 203-205
  • 8Latini R, Tognoni G, Maggioni AP, et al. Clinical effects of early angiotensin- converting enzyme inhibitor treatment for acute myocardial infarction. J Am Coll Cardiol, 2000, 35(7): 1801-1807
  • 9Aumegeat V, Lamblin N, de Groote P, et al. Aspirin does not adversely affect survival in patients with stable congestive heart failure treated with angiotensin- converting enzyme inhibitors. Chest, 2003, 124(4): 1250-1258
  • 10Echemann M, Alla F, Briancon S, et al. Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study). Eur J Heart Fail, 2002, 4(5): 647-654

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部